Beijing Wantai Biological Pharmacy Enterprise Co Ltd (603392) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.010x

Based on the latest financial reports, Beijing Wantai Biological Pharmacy Enterprise Co Ltd (603392) has a cash flow conversion efficiency ratio of 0.010x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥127.35 Million ≈ $18.63 Million USD) by net assets (CN¥12.27 Billion ≈ $1.80 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Beijing Wantai Biological Pharmacy Enter market cap and net worth for the company's overall valuation and market capitalisation.

Beijing Wantai Biological Pharmacy Enterprise Co Ltd - Cash Flow Conversion Efficiency Trend (2013–2025)

This chart illustrates how Beijing Wantai Biological Pharmacy Enterprise Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Beijing Wantai Biological Pharmacy Enterprise Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Beijing Wantai Biological Pharmacy Enterprise Co Ltd ranked by their cash flow conversion efficiency. Explore Beijing Wantai Biological Pharmacy Enter cash earnings quality to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Coca-Cola Icecek AS IS:CCOLA	0.047x
Glarun Technology Co Ltd SHG:600562	-0.001x
TAL Education Group NYSE:TAL	0.117x
APT Medical Inc SHG:688617	0.098x
Wuxi Taclink Optoelectronics Technology Co. Ltd. A SHG:688205	N/A
Western Superconducting Tech Co Ltd SHG:688122	-0.038x
Turkcell Iletisim Hizmetleri AS ORD IS:TCELL	0.103x
Global Business Travel Group Inc NYSE:GBTG	-0.009x

Annual Cash Flow Conversion Efficiency for Beijing Wantai Biological Pharmacy Enterprise Co Ltd (2013–2025)

The table below shows the annual cash flow conversion efficiency of Beijing Wantai Biological Pharmacy Enterprise Co Ltd from 2013 to 2025. View Beijing Wantai Biological Pharmacy Enter share price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥12.03 Billion ≈ $1.76 Billion	CN¥89.75 Million ≈ $13.13 Million	0.007x	-73.85%
2024-12-31	CN¥12.45 Billion ≈ $1.82 Billion	CN¥355.08 Million ≈ $51.96 Million	0.029x	-77.09%
2023-12-31	CN¥12.88 Billion ≈ $1.89 Billion	CN¥1.60 Billion ≈ $234.72 Million	0.125x	-62.15%
2022-12-31	CN¥12.56 Billion ≈ $1.84 Billion	CN¥4.13 Billion ≈ $604.73 Million	0.329x	-10.78%
2021-12-31	CN¥4.56 Billion ≈ $667.64 Million	CN¥1.68 Billion ≈ $246.12 Million	0.369x	+103.17%
2020-12-31	CN¥2.58 Billion ≈ $377.59 Million	CN¥468.21 Million ≈ $68.51 Million	0.181x	+5.19%
2019-12-31	CN¥1.58 Billion ≈ $231.31 Million	CN¥272.68 Million ≈ $39.90 Million	0.173x	+13.49%
2018-12-31	CN¥1.37 Billion ≈ $200.54 Million	CN¥208.31 Million ≈ $30.48 Million	0.152x	-7.02%
2017-12-31	CN¥898.99 Million ≈ $131.55 Million	CN¥146.97 Million ≈ $21.51 Million	0.163x	+21.25%
2016-12-31	CN¥959.70 Million ≈ $140.43 Million	CN¥129.40 Million ≈ $18.94 Million	0.135x	-35.82%
2015-12-31	CN¥722.69 Million ≈ $105.75 Million	CN¥151.84 Million ≈ $22.22 Million	0.210x	-7.93%
2014-12-31	CN¥580.32 Million ≈ $84.92 Million	CN¥132.43 Million ≈ $19.38 Million	0.228x	-10.88%
2013-12-31	CN¥382.06 Million ≈ $55.91 Million	CN¥97.83 Million ≈ $14.32 Million	0.256x	--

About Beijing Wantai Biological Pharmacy Enterprise Co Ltd

SHG:603392 China Biotechnology

Market Cap

$4.88 Billion

CN¥33.35 Billion CNY

Market Cap Rank

#3619 Global

#499 in China

Share Price

CN¥26.38

Change (1 day)

-2.04%

52-Week Range

CN¥24.97 - CN¥58.11

All Time High

CN¥142.90